Ricardo Morcos

Ricardo Morcos

Auto-generated profile, based on publicly available information

Ricardo Morcos

Epilepsy and Neurogenetics Unit, Vithas Madrid University Hospitals Universidad Europea de Madrid Madrid Spain

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2025 in Epilepsia
Verified
Journal Article
Open access
MRMarlene Rong
Marlene Rong
PMPaula T. Marques
Paula T. Marques
QAQuratulain Zulfiqar Ali
Quratulain Zulfiqar Ali
RMRicardo Morcos
Ricardo Morcos
ICIlakkiah Chandran
Ilakkiah Chandran
DADanielle M. Andrade
Danielle M. Andrade
Objective: Dravet syndrome (DS) is a developmental and epileptic encephalopathy. Diagnosis is clinical, but ~90% of patients have pathogenic variants in SCN1A . ATP6V0C has recently been proposed as a novel candidate gene for epilepsy, with or without developmental delay. Here we describe two adult patients with a clinical diagnosis of DS associated with ATP6V0C variants. Methods: Patients with developmental and epileptic encephalopathies were evaluated by physicians who are experts in DS, and their clinical diagnosis was correlated with genetic findings. A subgroup of those patients with DS but without known genetic causes were evaluated through gene panels, whole exome sequencing, and chromosome microarray. Phenotype was determined by pediatric and adult chart reviews, interviews, and physical examinations. Results: Of 753 patients with DS, two unrelated individuals with classic features of DS during childhood and adulthood were identified with heterozygous de novo missense variants in ATP6V0C (c.319G > C, p.(Gly107Arg) and c.284C > T, p.(Ala95Val), respectively). Both variants were absent in normal populations and computational prediction algorithms suggested deleterious effects on protein structure and/or function. No disease‐causing variants in other genes previously associated with DS were found. Significance: Here we describe two adult patients with Dravet‐like syndrome and pathogenic/likely pathogenic variants in ATP6V0C . We propose that abnormal ATP6V0C function can, at the severe end of the clinical spectrum, be associated with Dravet‐like phenotype. This is relevant, as these patients would not qualify for disease‐modifying antisense nucleotide or gene therapies targeting SCN1A .

20 June 2023 in Neurocirugia
Verified
Journal Article
Closed access
AMA. Mosteiro
A. Mosteiro
AFAbel Ferrés
Abel Ferrés
TTT.E. Topczewski
T.E. Topczewski
ARA. Rivero
A. Rivero
IAIban Aldecoa
Iban Aldecoa
JGJ.J. González-Sánchez
J.J. González-Sánchez